Cyclacel Pharmaceuticals Announces Publication Confirming Fadraciclib Suppresses MCL1 and Synergizes With Venetoclax in Chronic Lymphocytic Leukemia -New Preclinical Data Highlight Fadraciclib’s Apoptosis Enabling Mechanism in Leukemia- -Remarkable Synergy Observed with Venetoclax, esp. in Resistant CLL cells with 17p Deletion- BERKELEY HEIGHTS,...

Microdea Expands Partnership Ecosystem Leading TMS and telematics providers are integrating with Microdea’s mobile app and cloud-based document management solutions to drive efficiency gains for carriers and brokers. TORONTO, July 16,...

Microdea is Named to the 2017 List of Best Workplaces in Technology MARKHAM, Ontario, Oct. 03, 2017 (GLOBE NEWSWIRE) -- Microdea is proud to announce that our organization has been named to the 2017 LIST OF BEST WORKPLACES IN TECHNOLOGY   Microdea received this...

Microdea Makes the PROFIT 500 List for Fourth Consecutive Year MARKHAM, Ontario, Sept. 14, 2017 (GLOBE NEWSWIRE) -- Canadian Business and PROFIT today ranked Microdea No. 457 on the 29th annual PROFIT 500, the definitive ranking of Canada’s Fastest-Growing...